Fine Foods & Pharmaceuticals N.T.M Future Growth
Future criteria checks 4/6
Fine Foods & Pharmaceuticals N.T.M is forecast to grow earnings and revenue by 32.6% and 12% per annum respectively. EPS is expected to grow by 1.8% per annum. Return on equity is forecast to be 12.6% in 3 years.
Key information
32.6%
Earnings growth rate
1.8%
EPS growth rate
| Life Sciences earnings growth | 25.8% |
| Revenue growth rate | 12.0% |
| Future return on equity | 12.6% |
| Analyst coverage | Low |
| Last updated | 13 Aug 2024 |
Recent future growth updates
Recent updates
Is There An Opportunity With Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) 40% Undervaluation?
Apr 28
Estimating The Fair Value Of Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF)
Mar 20Something To Consider Before Buying Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) For The 1.1% Dividend
Feb 22A Look At Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Share Price Returns
Feb 01What You Need To Know About Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) Investor Composition
Jan 14We Wouldn't Rely On Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Statutory Earnings As A Guide
Dec 28Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?
Dec 08Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 350 | 18 | 13 | 38 | 1 |
| 12/31/2025 | 297 | 13 | -5 | 31 | 1 |
| 12/31/2024 | 273 | 10 | -32 | 26 | 2 |
| 6/30/2024 | 247 | 3 | 18 | 40 | N/A |
| 3/31/2024 | 252 | -4 | 9 | 28 | N/A |
| 12/31/2023 | 252 | -4 | 0 | 19 | N/A |
| 9/30/2023 | 240 | 1 | -7 | 10 | N/A |
| 6/30/2023 | 234 | -5 | -11 | 6 | N/A |
| 3/31/2023 | 222 | -4 | -7 | 10 | N/A |
| 12/31/2022 | 207 | -10 | -12 | 4 | N/A |
| 9/30/2022 | 203 | -10 | -18 | 2 | N/A |
| 6/30/2022 | 196 | -1 | -25 | -5 | N/A |
| 3/31/2022 | 194 | -6 | -25 | -7 | N/A |
| 12/31/2021 | 195 | -1 | -22 | -6 | N/A |
| 9/30/2021 | 198 | -1 | -6 | 7 | N/A |
| 6/30/2021 | 200 | 2 | 3 | 17 | N/A |
| 3/31/2021 | 190 | 13 | 4 | 18 | N/A |
| 12/31/2020 | 177 | 13 | 15 | 30 | N/A |
| 9/30/2020 | 162 | 8 | 2 | 19 | N/A |
| 6/30/2020 | 153 | -1 | 1 | 19 | N/A |
| 3/31/2020 | 157 | -2 | 0 | 19 | N/A |
| 12/31/2019 | 161 | -3 | -1 | 19 | N/A |
| 9/30/2019 | 157 | 8 | -6 | 17 | N/A |
| 6/30/2019 | 153 | 9 | -12 | 14 | N/A |
| 3/31/2019 | 147 | 9 | -52 | 6 | N/A |
| 12/31/2018 | 140 | 9 | -93 | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: FF's forecast earnings growth (32.6% per year) is above the savings rate (2.4%).
Earnings vs Market: FF's earnings (32.6% per year) are forecast to grow faster than the Italian market (7% per year).
High Growth Earnings: FF's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: FF's revenue (12% per year) is forecast to grow faster than the Italian market (3.9% per year).
High Growth Revenue: FF's revenue (12% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: FF's Return on Equity is forecast to be low in 3 years time (12.6%).